| UNH, TGT, BDX: 3 Ridiculously Undervalued Stocks Set to Surge in May 2025 |
These stocks have declined significantly in the past year and are now below their intrinsic values. |
247wallst.com |
2025-05-14 20:02:33 |
Czytaj oryginał (ang.) |
| Becton, Dickinson and Company (BDX) Bank of America Securities Health Care Conference - (Transcript) |
Becton, Dickinson and Company (NYSE:BDX ) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ET Company Participants Tom Polen - Chairman, Chief Executive Officer and President Conference Call Participants Travis Steed - Bank of America Securities Travis Steed [Starts Abruptly] I'm Travis Steed, Medical Device Analyst at Bank of America and I'm fortunate to have Tom Polen up next, CEO at Becton, Dickinson. So welcome. |
seekingalpha.com |
2025-05-14 01:44:30 |
Czytaj oryginał (ang.) |
| BD to Announce Financial Results for its Third Quarter of Fiscal 2025 |
FRANKLIN LAKES, N.J. , May 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. |
prnewswire.com |
2025-05-12 13:00:00 |
Czytaj oryginał (ang.) |
| Buy 3 "Safer" Dividend Kings Of 25 From May's 55 |
The May collection of Dividend Kings grew to 55, with Automatic Data Processing and RLI Corporation joining, despite two companies dropping off for not increasing dividends. Six top-yield Dividend Kings, including Altria and Canadian Utilities, are now fairly priced, with annual dividends from $1K investments exceeding their single-share prices. Analysts predict net gains of 14.7% to 56.86% for the top ten Dividend Kings by yield for the coming year, based on target prices. Among the 55 Dividend Kings, 16 show negative free cash flow margins, making them cash-poor and unsafe for investment. |
seekingalpha.com |
2025-05-06 16:58:48 |
Czytaj oryginał (ang.) |
| Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years |
Becton Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday. |
benzinga.com |
2025-05-02 20:33:42 |
Czytaj oryginał (ang.) |
| 9 Dividend Aristocrats Potentially Set To Soar, No Matter What Happens Next |
I'm going on a 2-week vacation with my family for my sister's wedding, so I've prepared a comprehensive article with three types of dividend aristocrat recommendations for whateveriscomingnext. Low-volatility aristocrats offer a 3.4% yield, a 46% downside capture ratio, and 52% less volatility than the S&P, making them ideal for addressing recession concerns while still providing a 23% return. High-yield aristocrats offer a 7% average yield with 11%-12% long-term return potential, providing low-risk income regardless of market or economic conditions. |
seekingalpha.com |
2025-05-02 11:00:00 |
Czytaj oryginał (ang.) |
| Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales |
Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its research instrument sales. |
marketwatch.com |
2025-05-01 17:46:00 |
Czytaj oryginał (ang.) |
| William Blair downgrades Becton Dickinson on 'disappointing' Q2 update |
01 May |
https://thefly.com |
2025-05-01 16:15:46 |
Czytaj oryginał (ang.) |
| Becton, Dickinson and Company (BDX) Q2 2025 Earnings Call Transcript |
Becton, Dickinson and Company (NYSE:BDX ) Q2 2025 Results Conference Call May 1, 2025 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer and Head of Investor Relations Tom Polen - Chairman, Chief Executive Officer and President Chris DelOrefice - Executive Vice President and Chief Financial Officer Mike Garrison - President of the Medical Mike Feld - President of the Life Sciences Rick Byrd - President of the Interventional Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Matt Taylor - Jefferies Travis Steed - Bank of America Patrick Wood - Morgan Stanley David Roman - Goldman Sachs Matt Miksic - Barclays Operator Hello, and welcome to BD's Second Fiscal Quarter 2025 Earnings Call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at (800) 839-2385 for domestic calls and area code +1-402-220-7203 for international calls. |
seekingalpha.com |
2025-05-01 15:44:06 |
Czytaj oryginał (ang.) |
| Becton Dickinson (BDX) Reports Q2 Earnings: What Key Metrics Have to Say |
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-05-01 14:36:32 |
Czytaj oryginał (ang.) |
| Cramer's Stop Trading: Becton Dickinson |
CNBC's Jim Cramer explains why he is keeping an eye on shares of Becton Dickinson. |
youtube.com |
2025-05-01 14:22:44 |
Czytaj oryginał (ang.) |
| Becton Dickinson (BDX) Q2 Earnings Top Estimates |
Becton Dickinson (BDX) came out with quarterly earnings of $3.35 per share, beating the Zacks Consensus Estimate of $3.28 per share. This compares to earnings of $3.17 per share a year ago. |
zacks.com |
2025-05-01 12:45:44 |
Czytaj oryginał (ang.) |
| Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit |
Medical device maker Becton Dickinson lowered its annual profit forecast on Thursday, in anticipation of a potential hit from U.S. President Donald Trump's tariffs, sending its shares down 5% in premarket trading. |
reuters.com |
2025-05-01 11:48:47 |
Czytaj oryginał (ang.) |
| BD Reports Second Quarter Fiscal 2025 Financial Results |
Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organic GAAP and adjusted diluted EPS of $1.07 and $3.35, respectively Company updates full-year fiscal 2025 guidance and provides estimated tariff impact FRANKLIN LAKES, N.J., May 1, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2025 second quarter, which ended March 31, 2025. |
prnewswire.com |
2025-05-01 10:30:00 |
Czytaj oryginał (ang.) |
| BD to Present at Bank of America Securities Health Care Conference |
FRANKLIN LAKES, N.J. , April 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference on Tuesday, May 13, 2025 at 1:00 pm Eastern Time. |
prnewswire.com |
2025-04-30 20:15:00 |
Czytaj oryginał (ang.) |
| MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK |
This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues. |
zacks.com |
2025-04-30 15:55:39 |
Czytaj oryginał (ang.) |
| Best Dividend Aristocrats For May 2025 |
Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Edison (+25.65%), Cardinal Health (+17.82%), and Coca-Cola (+16.18%). 33 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.33%. |
seekingalpha.com |
2025-04-30 00:07:22 |
Czytaj oryginał (ang.) |
| BD Board Declares Dividend |
FRANKLIN LAKES, N.J. , April 29, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, payable on June 30, 2025 to holders of record on June 9, 2025. |
prnewswire.com |
2025-04-29 20:20:00 |
Czytaj oryginał (ang.) |
| Can Sustained Product Demand Drive BDX Stock Before Q2 Earnings? |
The continued solid uptake of BD's products is expected to have driven fiscal second-quarter revenues despite transitory market dynamics. |
zacks.com |
2025-04-28 17:20:40 |
Czytaj oryginał (ang.) |
| Gear Up for Becton Dickinson (BDX) Q2 Earnings: Wall Street Estimates for Key Metrics |
Besides Wall Street's top -and-bottom-line estimates for Becton Dickinson (BDX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025. |
zacks.com |
2025-04-28 14:21:40 |
Czytaj oryginał (ang.) |
| Becton Dickinson (BDX) is a Top-Ranked Value Stock: Should You Buy? |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-01-03 12:46:04 |
Czytaj oryginał (ang.) |
| BDX vs. MMSI: Which Stock Is the Better Value Option? |
Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2025-01-01 14:51:07 |
Czytaj oryginał (ang.) |
| My Best Dividend Aristocrats For January 2025 |
The ProShares S&P 500 Dividend Aristocrat ETF rocked a cool 4.85% gain in November, but it's giving up nearly half of its return this year in December. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 41 months of tracking these strategies, two strategies are generating a CAGR superior to NOBL. |
seekingalpha.com |
2024-12-31 08:47:18 |
Czytaj oryginał (ang.) |
| 5 Top AI-in-MedTech Stocks for Big Gains in 2025: MDT, BSX & More |
Here we discuss five medical stocks - MDT, BSX, BDX, GEHC and TEM - incorporating AI in their workflows. These are likely to gain in 2025 as AI helps cut costs and improve patient care. |
zacks.com |
2024-12-30 10:31:10 |
Czytaj oryginał (ang.) |
| Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2024-12-20 12:46:33 |
Czytaj oryginał (ang.) |
| BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing |
The blood testing process integrating BD's MiniDraw System with Babson's BetterWay technologies is likely to lower common barriers to testing and improve patient outcomes. |
zacks.com |
2024-12-18 13:46:10 |
Czytaj oryginał (ang.) |
| Here's Why Becton Dickinson (BDX) is a Strong Value Stock |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2024-12-18 12:40:31 |
Czytaj oryginał (ang.) |
| Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2024-12-17 12:51:31 |
Czytaj oryginał (ang.) |
| BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations |
FRANKLIN LAKES, N.J. and AUSTIN, Texas , Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-first health care technology company, today announced an expansion of fingertip blood collection and testing technologies for use by U.S. health systems and other large provider networks in settings like urgent cares, doctor offices and other ambulatory care settings. |
prnewswire.com |
2024-12-17 08:50:00 |
Czytaj oryginał (ang.) |
| Becton Dickinson settles charges over infusion pump risks, SEC says |
The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. over allegations it misled investors about risks associated with its Alaris infusion pump. |
reuters.com |
2024-12-16 18:46:40 |
Czytaj oryginał (ang.) |
| Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump |
Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer known as BD, for repeatedly misleading investors about risks associated with its continued sales of its Alaris infusion pump and for overstating its income by failing to record the costs of fixing multiple software flaws with the pump. |
newsfilecorp.com |
2024-12-16 18:38:00 |
Czytaj oryginał (ang.) |
| BD Resolves Previously Disclosed SEC Investigation |
FRANKLIN LAKES, N.J. , Dec. 16, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement: BD has reached an agreement with the U.S. Securities and Exchange Commission (SEC) to resolve the previously disclosed investigation related to prior public disclosures and SEC reporting regarding the BD Alaris™ System, which was acquired by BD from CareFusion in 2015 and is part of the BD Medication Management Solutions business. |
prnewswire.com |
2024-12-16 18:32:00 |
Czytaj oryginał (ang.) |
| Zacks Industry Outlook Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems |
Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems have been highlighted in this Industry Outlook article. |
zacks.com |
2024-12-13 05:15:24 |
Czytaj oryginał (ang.) |
| 4 Stocks to Watch Amid Dental Supplies Industry Challenges |
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are BDX, MCK, CAH and MMSI. |
zacks.com |
2024-12-12 11:46:09 |
Czytaj oryginał (ang.) |
| Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025 |
Investing in blue-chip stocks at 52-week lows can potentially yield significant returns if fundamentals are strong. Avoid value traps by focusing on companies with solid fundamentals, like Elevance Health, Becton, Dickinson, LyondellBasell, Rogers Communications and Rexford Industrial Realty. These companies offer a 3.7% yield and a 27% discount to fair value, and they have historically outperformed the market with 27% less volatility. |
seekingalpha.com |
2024-12-12 09:00:00 |
Czytaj oryginał (ang.) |
| 12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style |
The S&P is up almost 28% in 2024, and many investors worry about a melt-up followed by a sharp correction like in 2022 or 2018. A 2025 market correction is likely, but low-volatility, high-yield Dividend Aristocrats offer a better alternative to the traditional 60-40 portfolio and S&P. These 12 Aristocrats provide a 3.2% yield, 14% discount, 22% upside potential next year, and 10% long-term income growth consensus, while being 54% lower volatility than the S&P. |
seekingalpha.com |
2024-12-07 09:00:00 |
Czytaj oryginał (ang.) |
| These 5 Stocks Have 50 Years of Dividend Growth—Here's How to Find More |
With a new presidential administration set to take office on Jan. 20, 2025, some investors may be uncertain about how new policies and personnel will affect the stock market and interest rates. Will tariffs, discarded trade deals, and frayed alliances help or hurt the market? |
investopedia.com |
2024-12-06 16:10:45 |
Czytaj oryginał (ang.) |
| 17 Upcoming Dividend Increases, Including A King |
With the holiday season underway, I present 17 companies with dividend increases for 2024, including Becton, Dickinson, and Company, a dividend king with a 52-year streak. My strategy focuses on buying, holding, and adding to companies with consistent dividend growth and outperforming benchmarks, using data from U.S. Dividend Champions and NASDAQ. I prioritize companies with strong historical returns and high 10-year dividend growth rates, comparing them against the Schwab U.S. Dividend Equity ETF. |
seekingalpha.com |
2024-12-05 13:08:55 |
Czytaj oryginał (ang.) |
| Becton, Dickinson and Company (BDX) 7th Annual Evercore ISI HealthCONx Conference (Transcript) |
Becton, Dickinson and Company (NYSE:BDX ) 7th Annual Evercore ISI HealthCONx Results Conference December 3, 2024 10:50 AM ET Company Participants Richard Byrd - EVP and President of Interventional Business Chris DelOrefice - Executive Vice President & Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Thanks, everyone, for joining us this morning. A pleasure to have with us Becton, Dickinson. |
seekingalpha.com |
2024-12-03 16:14:06 |
Czytaj oryginał (ang.) |
| Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2024-12-02 17:26:17 |
Czytaj oryginał (ang.) |